Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases
- 1 June 1997
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (6) , 678-682
- https://doi.org/10.1007/bf00841409
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Ergebnisse der Positronen- emissionstomographie mit Fluor-18-markierter Fluordesoxyglukose bei Differentialdiagnose und Staging des PankreaskarzinomsDer Radiologe, 1996
- Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.Radiology, 1995
- 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.Radiology, 1995
- Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problemEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.Radiology, 1994
- Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical studyCancer, 1993
- CT for Assessment of Pancreatic and Periampullary CancerActa Radiologica, 1993
- Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma.Radiology, 1992
- Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy.Radiology, 1991